Whether you are a new T1D Family, a TrialNet participant, a healthcare provider, or a researcher — you'll find resources here.
We’re here to help you after a new T1D diagnosis. Get answers to frequently asked questions and learn about clinical studies testing ways to maintain insulin production.
While you wait for screening results, get answers to your questions, find out about next steps, and learn more about TrialNet’s Pathway to Prevention.
Your T1D families are important to you. Learn how easy it is to connect your patients with world-class T1D research.
If your screening results show that you have two or more diabetes-related autoantibodies, and there’s not a prevention study that’s right for you at this time, you can opt in for monitoring and make a lasting contribution to T1D research. You’ll be closely monitored by experts at the forefront of T1D research.
If your screening results show that you have two or more diabetes-related autoantibodies and there’s not a prevention study that’s right for you at this time, you can still make a lasting contribution to T1D research.
When you sign up for monitoring, you’ll come to a TrialNet location once or twice a year for follow up. And, when new studies become available, you’ll be among the first to know!
You may qualify for monitoring if you participated in Pathway to Prevention screening and tested positive for two or more diabetes-related autoantibodies.